HIV, Antiretroviral Therapy, and Hypertensive Disorders in Pregnancy: A Systematic Review and Meta-analysis
- PMID: 26322669
- DOI: 10.1097/QAI.0000000000000686
HIV, Antiretroviral Therapy, and Hypertensive Disorders in Pregnancy: A Systematic Review and Meta-analysis
Abstract
Background: There are data to suggest that infection with HIV or use of highly active antiretroviral therapy increases the risk of hypertensive disorders in pregnancy. This systematic review and meta-analysis aims to provide an overview of the research hitherto.
Methods: A systematic review of EMBASE, PubMed, and The Cochrane Library databases was conducted to obtain articles about the association between HIV in pregnancy and/or HIV therapy and the risk of developing pregnancy-induced hypertension (PIH), pre-eclampsia, eclampsia, or Hemolysis Elevated Liver enzymes Low Platelet count syndrome. Quality of articles was evaluated with an adapted Cochrane Collaboration bias assessment tool. Relative risks (RRs) were pooled with a random-effects meta-analysis weighted by the inverse of their variance.
Results: Of the 2136 articles screened, 28 studies were eligible for inclusion; 15 studies reported on the association with PIH, 16 on pre-eclampsia, 5 on eclampsia, and 3 articles on HIV therapy regimens. All articles had a high risk of bias, and between-study heterogeneity was considerable. Based on the meta-analysis, there does not seem to be an association between HIV and PIH [RR 1.26, 95% confidence interval (CI): 0.87 to 1.83, I = 78.6%], pre-eclampsia (RR 1.01, 95% CI: 0.87 to 1.18, I = 63.9%), or eclampsia (RR 1.61, 95% CI: 0.14 to 18.68, I = 97.0%). A meta-analysis of the association with HIV therapy and risk of hypertensive disorders in pregnancy could not be performed.
Conclusions: This meta-analysis shows no significant association between HIV positivity and PIH, pre-eclampsia, or eclampsia. However, the high risk of bias within most studies limits the strength of conclusions and well-designed studies are necessary to confirm or refute these findings.
Similar articles
-
Combined antiretroviral therapy for HIV and the risk of hypertensive disorders of pregnancy: A systematic review.Pregnancy Hypertens. 2019 Jul;17:178-190. doi: 10.1016/j.preghy.2019.05.015. Epub 2019 May 17. Pregnancy Hypertens. 2019. PMID: 31487638 Free PMC article.
-
The association between HIV, antiretroviral therapy, and gestational diabetes mellitus.AIDS. 2017 Jan 2;31(1):113-125. doi: 10.1097/QAD.0000000000001277. AIDS. 2017. PMID: 27677165 Review.
-
A systematic review of the effect of HIV infection and antiretroviral therapy on the risk of pre-eclampsia.Int J Gynaecol Obstet. 2016 Apr;133(1):17-21. doi: 10.1016/j.ijgo.2015.08.007. Epub 2015 Dec 11. Int J Gynaecol Obstet. 2016. PMID: 26797203 Review.
-
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.Cochrane Database Syst Rev. 2010 Mar 17;(3):CD008440. doi: 10.1002/14651858.CD008440. Cochrane Database Syst Rev. 2010. PMID: 20238370 Review.
-
Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome.Int J Gynaecol Obstet. 2001 Jan;72(1):17-23. doi: 10.1016/s0020-7292(00)00281-2. Int J Gynaecol Obstet. 2001. PMID: 11146072
Cited by
-
Cardiometabolic Health in Pregnancy and Postpartum: Findings From a Prospective Cohort Study in South Africa.Open Forum Infect Dis. 2024 Feb 22;11(3):ofae093. doi: 10.1093/ofid/ofae093. eCollection 2024 Mar. Open Forum Infect Dis. 2024. PMID: 38481429 Free PMC article.
-
Comparative risk of adverse perinatal outcomes associated with classes of antiretroviral therapy in pregnant women living with HIV: systematic review and meta-analysis.Front Med (Lausanne). 2024 Feb 27;11:1323813. doi: 10.3389/fmed.2024.1323813. eCollection 2024. Front Med (Lausanne). 2024. PMID: 38476445 Free PMC article.
-
Antiretroviral Options and Treatment Decisions During Pregnancy.Paediatr Drugs. 2023 May;25(3):267-282. doi: 10.1007/s40272-023-00559-w. Epub 2023 Feb 2. Paediatr Drugs. 2023. PMID: 36729360 Review.
-
Antiretroviral Therapy and Adverse Pregnancy Outcomes in People Living with HIV.N Engl J Med. 2023 Jan 26;388(4):344-356. doi: 10.1056/NEJMra2212877. N Engl J Med. 2023. PMID: 36720135 Free PMC article. Review. No abstract available.
-
Vascular Endothelial Growth Factor Receptor 2: Molecular Mechanism and Therapeutic Potential in Preeclampsia Comorbidity with Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections.Int J Mol Sci. 2022 Nov 9;23(22):13752. doi: 10.3390/ijms232213752. Int J Mol Sci. 2022. PMID: 36430232 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical